{"product_id":"gore®-acuseal-vascular-graft","title":"Gore Medical GORE® ACUSEAL Vascular Graft","description":"\u003cdiv class=\"product-overview\"\u003e\n  \u003ch3\u003eGORE® ACUSEAL Vascular Graft by Gore Medical\u003c\/h3\u003e\n\n  \u003cp\u003e\n    The GORE® ACUSEAL Vascular Graft is a purpose-built hemodialysis access graft designed for early cannulation, allowing dialysis access within 24 hours when clinically appropriate. It provides an immediate vascular access option that may help reduce the need for prolonged central venous catheter use.\n  \u003c\/p\u003e\n\n  \u003cp\u003e\n    Designed for patients who require rapid dialysis access, including those at risk of fistula non-maturation or those already using a central venous catheter, the GORE® ACUSEAL Vascular Graft combines a tri-layer structure, heparin surface technology, and flexible handling for reliable vascular access placement.\n  \u003c\/p\u003e\n\u003c\/div\u003e\n\n\u003cdiv class=\"product-applications\"\u003e\n  \u003ch3\u003eClinical Applications\u003c\/h3\u003e\n\n  \u003cp\u003e\n    GORE® ACUSEAL Vascular Graft is used for hemodialysis access when early cannulation and timely vascular access are required.\n  \u003c\/p\u003e\n\n  \u003cdiv style=\"display:grid;grid-template-columns:repeat(2,minmax(0,1fr));gap:20px;margin:28px 0;\"\u003e\n    \u003cdiv style=\"padding:22px;border-radius:18px;background:#fbf8fd;border:1px solid rgba(111,44,145,0.10);\"\u003e\n      \u003ch4\u003eHemodialysis Access\u003c\/h4\u003e\n      \u003cul\u003e\n        \u003cli\u003eEarly cannulation vascular access\u003c\/li\u003e\n        \u003cli\u003eDialysis access within 24 hours when clinically appropriate\u003c\/li\u003e\n        \u003cli\u003eSupport for patients requiring access in under two weeks\u003c\/li\u003e\n      \u003c\/ul\u003e\n    \u003c\/div\u003e\n\n    \u003cdiv style=\"padding:22px;border-radius:18px;background:#fbf8fd;border:1px solid rgba(111,44,145,0.10);\"\u003e\n      \u003ch4\u003eCVC Reduction Support\u003c\/h4\u003e\n      \u003cul\u003e\n        \u003cli\u003eMay support earlier central venous catheter removal\u003c\/li\u003e\n        \u003cli\u003eOption for patients at risk of fistula non-maturation\u003c\/li\u003e\n        \u003cli\u003eImmediate access solution for selected dialysis patients\u003c\/li\u003e\n      \u003c\/ul\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003cdiv class=\"product-features\"\u003e\n  \u003ch3\u003eKey Features\u003c\/h3\u003e\n\n  \u003cdiv style=\"display:grid;grid-template-columns:repeat(2,minmax(0,1fr));gap:20px;margin:28px 0;\"\u003e\n    \u003cdiv style=\"padding:22px;border-radius:18px;background:#fbf8fd;border:1px solid rgba(111,44,145,0.10);\"\u003e\n      \u003ch4\u003eEarly Cannulation\u003c\/h4\u003e\n      \u003cp\u003e\n        Designed to support cannulation within 24 hours when clinically appropriate, helping provide timely hemodialysis access.\n      \u003c\/p\u003e\n    \u003c\/div\u003e\n\n    \u003cdiv style=\"padding:22px;border-radius:18px;background:#fbf8fd;border:1px solid rgba(111,44,145,0.10);\"\u003e\n      \u003ch4\u003eTri-Layer Design\u003c\/h4\u003e\n      \u003cp\u003e\n        The graft features an elastomeric middle layer that acts as a low-bleed barrier to cannulation needle holes while maintaining practical surgical handling.\n      \u003c\/p\u003e\n    \u003c\/div\u003e\n\n    \u003cdiv style=\"padding:22px;border-radius:18px;background:#fbf8fd;border:1px solid rgba(111,44,145,0.10);\"\u003e\n      \u003ch4\u003eCBAS® Heparin Surface Technology\u003c\/h4\u003e\n      \u003cp\u003e\n        CBAS® Heparin Surface Technology is designed to resist thrombosis, a leading cause of arteriovenous graft failure.\n      \u003c\/p\u003e\n    \u003c\/div\u003e\n\n    \u003cdiv style=\"padding:22px;border-radius:18px;background:#fbf8fd;border:1px solid rgba(111,44,145,0.10);\"\u003e\n      \u003ch4\u003eFlexible Construction\u003c\/h4\u003e\n      \u003cp\u003e\n        Flexible graft construction supports placement around curves while helping reduce the risk of kinking.\n      \u003c\/p\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003cdiv class=\"product-outcomes\"\u003e\n  \u003ch3\u003eReported Clinical Outcomes\u003c\/h3\u003e\n\n  \u003cp\u003e\n    GORE® ACUSEAL Vascular Graft is designed to support earlier access and reduce reliance on central venous catheters in selected patients.\n  \u003c\/p\u003e\n\n  \u003cdiv style=\"display:grid;grid-template-columns:repeat(2,minmax(0,1fr));gap:20px;margin:28px 0;\"\u003e\n    \u003cdiv style=\"padding:22px;border-radius:18px;background:#fbf8fd;border:1px solid rgba(111,44,145,0.10);\"\u003e\n      \u003ch4\u003eReduced CVC Risk\u003c\/h4\u003e\n      \u003cul\u003e\n        \u003cli\u003eReported 5× lower risk of infection compared with CVC\u003c\/li\u003e\n        \u003cli\u003eReported 3× lower risk of mortality compared with CVC\u003c\/li\u003e\n        \u003cli\u003eMay reduce cost related to CVC sepsis by enabling earlier CVC removal\u003c\/li\u003e\n      \u003c\/ul\u003e\n    \u003c\/div\u003e\n\n    \u003cdiv style=\"padding:22px;border-radius:18px;background:#fbf8fd;border:1px solid rgba(111,44,145,0.10);\"\u003e\n      \u003ch4\u003ePatency and Clot-Free Survival\u003c\/h4\u003e\n      \u003cul\u003e\n        \u003cli\u003eReported 78% secondary patency at 12 months\u003c\/li\u003e\n        \u003cli\u003eReported 78% clot-free survival at one year\u003c\/li\u003e\n        \u003cli\u003eDesigned to support reliable dialysis access outcomes\u003c\/li\u003e\n      \u003c\/ul\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003cdiv class=\"product-specifications\"\u003e\n  \u003ch3\u003eAvailable Sizes\u003c\/h3\u003e\n\n  \u003ctable class=\"item_ptb dl_btop\"\u003e\n    \u003cthead\u003e\n      \u003ctr\u003e\n        \u003cth\u003eItem Number\u003c\/th\u003e\n        \u003cth\u003eDescription\u003c\/th\u003e\n      \u003c\/tr\u003e\n    \u003c\/thead\u003e\n\n    \u003ctbody\u003e\n      \u003ctr\u003e\n        \u003ctd\u003eECH060040\u003c\/td\u003e\n        \u003ctd\u003e6 mm × 40 cm | Heparin\u003c\/td\u003e\n      \u003c\/tr\u003e\n\n      \u003ctr\u003e\n        \u003ctd\u003eECH470045\u003c\/td\u003e\n        \u003ctd\u003e4–7 mm × 45 cm | Tapered | Heparin\u003c\/td\u003e\n      \u003c\/tr\u003e\n    \u003c\/tbody\u003e\n  \u003c\/table\u003e\n\u003c\/div\u003e\n\n\u003cdiv class=\"product-summary\"\u003e\n  \u003ch3\u003eEarly Cannulation Hemodialysis Access Graft\u003c\/h3\u003e\n\n  \u003cp\u003e\n    The GORE® ACUSEAL Vascular Graft provides an early cannulation vascular access solution for selected hemodialysis patients. Its tri-layer low-bleed design, CBAS® Heparin Surface Technology, flexible construction, and available straight or tapered configurations make it suitable for vascular access procedures where rapid dialysis access and reduced CVC dependence are important clinical considerations.\n  \u003c\/p\u003e\n\u003c\/div\u003e","brand":"Gore Medical","offers":[{"title":"Default Title","offer_id":45692803022927,"sku":null,"price":0.0,"currency_code":"AED","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/1746\/3887\/files\/16-9_peripheral-acuseal-vg_thumbnail_0.avif?v=1781258698","url":"https:\/\/ammtuae.com\/products\/gore%c2%ae-acuseal-vascular-graft","provider":"AMMT","version":"1.0","type":"link"}